This suppression of pro-angiogenic gene expression may occur through the known menin-binding partner JunD [52,236], which has previously been shown to reduce tumor angiogenesis in subcutaneous tumors formed by Kras mutant MEFs [237]. This evidence concerns the gene KRAS and neoplasm.